Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBM47 antisense RNA 1 (RBM47-AS1) is a long non-coding RNA gene transcribed in the antisense orientation relative to the RBM47 gene, which encodes the RNA-binding motif protein 47[4]. There is limited published information regarding the specific functions of RBM47-AS1, its involvement in cellular biology, or its relevance as a therapeutic target. It is not recognized as a canonical receptor, enzyme, transporter, or other typical therapeutic target class. No known drugs target RBM47-AS1, and it is not considered a disease biomarker. Its role appears limited to possible gene regulation at the RNA level, but this remains to be validated.\n\nNo evidence indicates that the query is misspelled or otherwise incorrect, but RBM47-AS1 should not be confused with the protein-coding RBM47 gene, which is a functionally characterized RNA-binding protein involved in interferon signaling and tumor suppression[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBM47 antisense RNA 1 (RBM47-AS1).